Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family

Carcinogenesis

Volumn 36, Issue 4, 2014, Pages 452-458

  Cini, Giulia ^a   Carnevali, Ileana ^b   Quaia, Michele ^a   Chiaravalli, Anna Maria ^b   Sala, Paola ^c   Giacomini, Elisa ^a   Maestro, Roberta ^a   Tibiletti, Maria Grazia ^b   Viel, Alessandra ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

^c IRCCS INT Milano   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1; ADENOSINE TRIPHOSPHATASE; DNA BINDING PROTEIN; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PMS2 PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; FEMALE; GENE INACTIVATION; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; BIOSYNTHESIS; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; GERMLINE MUTATION; MISMATCH REPAIR; NUCLEOTIDE SEQUENCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; BASE SEQUENCE; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA METHYLATION; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION;

EID: 84927594371     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv015     Document Type: Article

References (37)

1. Lynch, H.T. et al. (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin. Genet., 76, 1-18.
2. Hegde, M. et al. (2014) ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis). Genet. Med., 16, 101-116.
3. Leach, F.S. et al. (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell, 75, 1215-1225.
4. Fishel, R. et al. (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75, 1027-1038.
5. Miyaki, M. et al. (1997) Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat. Genet., 17, 271-272.
6. Bronner, C.E. et al. (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature, 368, 258-261.
7. Papadopoulos, N. et al. (1994) Mutation of a mutL homolog in hereditary colon cancer. Science, 263, 1625-1629.
8. Nicolaides, N.C. et al. (1994) Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature, 371, 75-80.
9. Peltomäki, P. et al. (1993) Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res., 53, 5853-5855.
10. Engel, C. et al. (2012) Risks of less common cancers in proven mutation carriers with lynch syndrome. J. Clin. Oncol., 30, 4409-4415.
11. Bonadona, V. et al. (2011) Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA, 305, 2304-2310.
12. Sharma, S. et al. (2010) Epigenetics in cancer. Carcinogenesis, 31, 27-36.
13. Kulis, M. et al. (2013) Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer. Biochim. Biophys. Acta, 1829, 1161-1174.
14. Lao, V.V. et al. (2011) Epigenetics and colorectal cancer. Nat. Rev. Gastroenterol. Hepatol., 8, 686-700.
15. Kane, M.F. et al. (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res., 57, 808-811.
16. Deng, G. et al. (1999) Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res., 59, 2029-2033.
17. Cancer Genome Atlas Network. (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487, 330-337.
18. Hitchins, M. et al. (2005) MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology, 129, 1392-1399.
19. Hitchins, M.P. (2013) The role of epigenetics in Lynch syndrome. Fam. Cancer, 12, 189-205.
20. Peltomäki, P. (2014) Epigenetic mechanisms in the pathogenesis of Lynch syndrome. Clin. Genet., 85, 403-412.
21. Gylling, A. et al. (2009) Large genomic rearrangements and germline epimutations in Lynch syndrome. Int. J. Cancer, 124, 2333-2340.
22. Morak, M. et al. (2011) Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome. J. Med. Genet., 48, 513-519.
23. Ward, R.L. et al. (2013) Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry. Genet. Med., 15, 25-35.
24. Kwok, C.T. et al. (2014) The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype. Eur. J. Hum. Genet., 22, 617-624.
25. Li, L.C. et al. (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics, 18, 1427-1431.
26. Bernasconi, B. et al. (2012) Genetic heterogeneity in HER2 testing may influence therapy eligibility. Breast Cancer Res. Treat., 133, 161-168.
27. Tang, Y. et al. (2012) Demethylation of the region around exon 2 of MLH1 gene in gastrointestinal cancer. Anticancer Res., 32, 4861-4864.
28. Crépin, M. et al. (2012) Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility. Hum. Mutat., 33, 180-188.
29. Hitchins, M.P. et al. (2011) Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5'UTR. Cancer Cell, 20, 200-213.
30. Pastrello, C. et al. (2011) Integrated analysis of unclassified variants in mismatch repair genes. Genet. Med., 13, 115-124.
31. Thompson, B.A. et al. (2014) Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat. Genet., 46, 107-115.
32. Jones, P.A. (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet., 13, 484-492.
33. You, J.S. et al. (2012) Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell, 22, 9-20.
34. Ligtenberg, M.J. et al. (2013) EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients. Fam. Cancer, 12, 169-174.
35. Pineda, M. et al. (2012) MLH1 methylation screening is effective in identifying epimutation carriers. Eur. J. Hum. Genet., 20, 1256-1264.
36. Goel, A. et al. (2011) De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one. Int. J. Cancer, 128, 869-878.
37. Crucianelli, F. et al. (2014) MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria. Epigenetics, 9, 1431-1438.